Literature DB >> 24008086

Factors in conversion from minimally invasive parathyroidectomy to bilateral parathyroid exploration for primary hyperparathyroidism.

David T Hughes1, Barbra S Miller, Paul B Park, Mark S Cohen, Gerard M Doherty, Paul G Gauger.   

Abstract

BACKGROUND: Ongoing experience has documented equivalence of minimally invasive parathyroidectomy (MIP) and standard bilateral parathyroid exploration (BPE) for primary hyperparathyroidism in most patients; however, intraoperative conversion of MIP to BPE is required for multiple indications. This study analyzes the factors, predictors, and cure rates in converted MIP.
METHODS: We retrospectively analyzed a database of 1,002 patients undergoing initial parathyroidectomy for primary hyperparathyroidism from 2008 to 2011 for rate of successful MIP, converted MIP, planned BPE, and factors leading to conversion from MIP to BPE.
RESULTS: Of 989 included parathyroidectomies, 647 (65%) were successful MIP, 186 (19%) were converted MIP, and 156 (16%) were planned BPE. The most common indication for conversion included intraoperative parathyroid hormone (IOPTH) criteria not met (46%), localization incorrect (36%), and evidence of multigland disease (17%). Converted MIP had lower preoperative calcium and PTH and lower baseline IOPTH compared with successful MIP. Complication rates were similar; however, rates of persistent hyperparathyroidism were highest in converted MIPs (6%) versus planned BPEs (3%) and successful MIPs (2%; P < .01).
CONCLUSION: Patients requiring conversion of MIP to BPE have lower preoperative serum calcium and PTH levels, a less dramatic decrease in IOPTH, and a greater rate of persistent disease than successful MIP.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24008086     DOI: 10.1016/j.surg.2013.04.020

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

Review 1.  Persistent and recurrent hyperparathyroidism.

Authors:  Carole Guerin; Nunzia Cinzia Paladino; Aoife Lowery; Fréderic Castinetti; David Taieb; Fréderic Sebag
Journal:  Updates Surg       Date:  2017-04-22

2.  18F-Fluorocholine PET/CT as a second line nuclear imaging technique before surgery for primary hyperparathyroidism.

Authors:  Alessio Imperiale; David Taïeb; Elif Hindié
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04       Impact factor: 9.236

Review 3.  Primary hyperparathyroidism.

Authors:  Tarıq Madkhali; Amal Alhefdhi; Herbert Chen; Dawn Elfenbein
Journal:  Ulus Cerrahi Derg       Date:  2016-03-01

4.  Comparison of minimally invasive parathyroidectomy under local anaesthesia and minimally invasive video-assisted parathyroidectomy for primary hyperparathyroidism: a cost analysis.

Authors:  G I Melfa; C Raspanti; M Attard; G Cocorullo; A Attard; S Mazzola; G Salamone; G Gulotta; G Scerrino
Journal:  G Chir       Date:  2016 Mar-Apr

Review 5.  Outcomes of Parathyroidectomy in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-analysis.

Authors:  Naykky M Singh Ospina; Rene Rodriguez-Gutierrez; Spyridoula Maraka; Ana E Espinosa de Ycaza; Sina Jasim; Ana Castaneda-Guarderas; Michael R Gionfriddo; Alaa Al Nofal; Juan P Brito; Patricia Erwin; Melanie Richards; Robert Wermers; Victor M Montori
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

6.  Intraoperative scintigraphy using a large field-of-view portable gamma camera for primary hyperparathyroidism: initial experience.

Authors:  Nathan C Hall; Robert L Plews; Amit Agrawal; Stephen P Povoski; Chadwick L Wright; Jun Zhang; Edward W Martin; John Phay
Journal:  Biomed Res Int       Date:  2015-01-06       Impact factor: 3.411

Review 7.  Routine bilateral neck exploration and four-gland dissection remains unnecessary in modern parathyroid surgery.

Authors:  Nathaniel J Walsh; Brian T Sullivan; William S Duke; David J Terris
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-11-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.